Mingxiang Cai

872 total citations
25 papers, 682 citations indexed

About

Mingxiang Cai is a scholar working on Molecular Biology, Cancer Research and Biomaterials. According to data from OpenAlex, Mingxiang Cai has authored 25 papers receiving a total of 682 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 14 papers in Cancer Research and 3 papers in Biomaterials. Recurrent topics in Mingxiang Cai's work include MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Mingxiang Cai is often cited by papers focused on MicroRNA in disease regulation (11 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (5 papers). Mingxiang Cai collaborates with scholars based in China. Mingxiang Cai's co-authors include Xiaogang Wang, Yao Sun, Zuolin Wang, Jia Xiao, Li Yang, Xiangning Liu, Mu Zhu, Jiafan Liu, Sumin Hu and An Hong and has published in prestigious journals such as Nature Communications, ACS Nano and PLoS ONE.

In The Last Decade

Mingxiang Cai

25 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mingxiang Cai China 13 515 361 95 88 58 25 682
Haoyu Guo China 13 387 0.8× 188 0.5× 182 1.9× 56 0.6× 95 1.6× 27 659
Zhendong Liu China 14 303 0.6× 176 0.5× 29 0.3× 67 0.8× 24 0.4× 51 503
Lianbi Zhao China 10 691 1.3× 337 0.9× 94 1.0× 43 0.5× 41 0.7× 17 825
Jun‐Jie Wu China 12 257 0.5× 63 0.2× 63 0.7× 58 0.7× 67 1.2× 25 542
José H. Teixeira Portugal 12 357 0.7× 202 0.6× 59 0.6× 19 0.2× 29 0.5× 12 493
Zhibo Sun China 14 215 0.4× 156 0.4× 39 0.4× 64 0.7× 29 0.5× 35 479
Uma Thanigai Arasu Finland 11 358 0.7× 151 0.4× 39 0.4× 38 0.4× 27 0.5× 13 467
Xianchao Kong China 7 342 0.7× 173 0.5× 52 0.5× 30 0.3× 34 0.6× 15 457
Qiqi Liu China 10 378 0.7× 183 0.5× 62 0.7× 62 0.7× 40 0.7× 21 493

Countries citing papers authored by Mingxiang Cai

Since Specialization
Citations

This map shows the geographic impact of Mingxiang Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingxiang Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingxiang Cai more than expected).

Fields of papers citing papers by Mingxiang Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingxiang Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingxiang Cai. The network helps show where Mingxiang Cai may publish in the future.

Co-authorship network of co-authors of Mingxiang Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Mingxiang Cai. A scholar is included among the top collaborators of Mingxiang Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingxiang Cai. Mingxiang Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Che, Zhaodi, Mingxiang Cai, Xiaowu Dong, et al.. (2025). Angiotensinogen inhibition concurrently mitigates alcohol-associated hepatic and muscle injury. Metabolism. 169. 156275–156275. 1 indexed citations
2.
Chen, Dan, et al.. (2025). Extracellular vesicles as vital players in drug delivery: a focus on clinical disease treatment. Frontiers in Bioengineering and Biotechnology. 13. 1600227–1600227. 4 indexed citations
3.
Liu, Minyi, et al.. (2023). Prospective applications of extracellular vesicle-based therapies in regenerative medicine: implications for the use of dental stem cell-derived extracellular vesicles. Frontiers in Bioengineering and Biotechnology. 11. 1278124–1278124. 6 indexed citations
4.
Cai, Mingxiang, Minyi Liu, Maohua Huang, et al.. (2023). Vascular Pericyte-Derived Exosomes Inhibit Bone Resorption via Traf3. International Journal of Nanomedicine. Volume 18. 7065–7077. 7 indexed citations
5.
Ma, Shiqing, Pengfei Wei, Jing Wei, et al.. (2023). Modification of the small intestinal submucosa membrane with oligopeptides screened from intrinsically disordered regions to promote angiogenesis and accelerate wound healing. Biomaterials Advances. 148. 213360–213360. 5 indexed citations
6.
Cai, Mingxiang, Fujun Jin, Junhui Li, et al.. (2022). Generation of functional oligopeptides that promote osteogenesis based on unsupervised deep learning of protein IDRs. Bone Research. 10(1). 23–23. 13 indexed citations
7.
Zhang, Yehui, Mingxiang Cai, Haisheng You, et al.. (2022). Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case–control study. Journal of Endocrinological Investigation. 45(11). 2123–2130. 3 indexed citations
8.
Liu, Meijing, Fujun Jin, Shuang Li, et al.. (2022). Activation of farnesoid X receptor signaling by geniposidic acid promotes osteogenesis. Phytomedicine. 103. 154258–154258. 9 indexed citations
9.
Li, Junhui, et al.. (2022). A mouse model of disuse osteoporosis based on a movable noninvasive 3D-printed unloading device. Journal of Orthopaedic Translation. 33. 1–12. 9 indexed citations
10.
Cai, Mingxiang, Yinping Tian, Yan Liang, et al.. (2022). Osteogenic peptides in periodontal ligament stem cell-containing three-dimensional bioscaffolds promote bone healing. Biomaterials Science. 10(7). 1765–1775. 3 indexed citations
11.
Jin, Fujun, Junhui Li, Yong‐Biao Zhang, et al.. (2021). A functional motif of long noncoding RNA Nron against osteoporosis. Nature Communications. 12(1). 3319–3319. 55 indexed citations
12.
Sun, Yao, Mingxiang Cai, Jiayong Zhong, et al.. (2019). The long noncoding RNA lnc-ob1 facilitates bone formation by upregulating Osterix in osteoblasts. Nature Metabolism. 1(4). 485–496. 47 indexed citations
13.
Cai, Mingxiang, Junhui Li, Rui Yue, Zuolin Wang, & Yao Sun. (2019). Glycosylation of DMP1 maintains cranial sutures in mice. Journal of Oral Rehabilitation. 47(S1). 19–28. 4 indexed citations
14.
Yang, Shihua, Wenhui Zhang, Mingxiang Cai, et al.. (2018). Suppression of Bone Resorption by miR-141 in Aged Rhesus Monkeys. Journal of Bone and Mineral Research. 33(10). 1799–1812. 25 indexed citations
15.
Cai, Mingxiang, et al.. (2017). A bone-resorption surface-targeting nanoparticle to deliver anti-miR214 for osteoporosis therapy. International Journal of Nanomedicine. Volume 12. 7469–7482. 51 indexed citations
16.
Zhu, Mu, Jiafan Liu, Jia Xiao, et al.. (2017). Lnc-mg is a long non-coding RNA that promotes myogenesis. Nature Communications. 8(1). 14718–14718. 177 indexed citations
17.
Hou, Likun, Yu‐Shui Ma, Yang Han, et al.. (2017). Association of microRNA-33a Molecular Signature with Non-Small Cell Lung Cancer Diagnosis and Prognosis after Chemotherapy. PLoS ONE. 12(1). e0170431–e0170431. 28 indexed citations
18.
Lu, Gai‐Xia, Yu‐Shui Ma, Chengyou Jia, et al.. (2017). Reduced miR‑125a levels associated with poor survival of patients with hepatocellular cancer. Oncology Letters. 14(5). 5952–5958. 13 indexed citations
19.
Sun, Yao, Mingxiang Cai, Xiangning Liu, et al.. (2016). Osteoblast-Targeting-Peptide Modified Nanoparticle for siRNA/microRNA Delivery. ACS Nano. 10(6). 5759–5768. 137 indexed citations
20.
Shi, Huihui, et al.. (2014). Update meta-analysis on 1790G/A polymorphism and cancer risk: Evidence from 26 studies. Neoplasma. 61(3). 340–351. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haoyu Guo Breakdown of academic impact, for papers by Zhendong Liu Breakdown of academic impact, for papers by Lianbi Zhao Breakdown of academic impact, for papers by Jun‐Jie Wu Breakdown of academic impact, for papers by José H. Teixeira Breakdown of academic impact, for papers by Zhibo Sun Breakdown of academic impact, for papers by Uma Thanigai Arasu Breakdown of academic impact, for papers by Xianchao Kong Breakdown of academic impact, for papers by Qiqi Liu
Rankless by CCL
2026